The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A new study among people entering prison in the USA suggests ‘opt-out’ testing approaches for HIV and hepatitis C virus (HCV) may need reconsideration.
Increasing numbers of people co-infected with HIV and hepatitis C (HCV) are accessing treatment for HCV as antivirals become more effective – but challenges beyond increasing access, remain.
Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.
Research reveals that most gay and bisexual men who stop taking pre-exposure prophylaxis (PrEP) in the USA do so because it is too expensive or they see themselves as no longer having a need for it.
Nearly one-fifth (19%) of all cancers among people living with HIV could have been avoided by not smoking according to a recent study among people living with HIV in North America.
With three in ten gay men living with HIV engaging in chemsex in the last year in the UK, understanding its association with the country’s HIV and STI epidemics is critical to put an end to new infections.
New research compares treatment outcomes of single versus multiple tablet regimes, raising questions around cost-effectiveness.
New research shows that food insecurity can impact treatment outcomes for people living with HIV and hepatitis C (HCV) co-infection.
‘Encouraging’ study casts first light on PrEP-related stigma among gay and bisexual men on dating apps, following concerns about growing negative attitudes towards PrEP users.
Testing for HIV is rising in the UK, but opportunities are being missed among some vulnerable groups.
